Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Immunology|December 24, 2019
The potential application of PD-1 blockade therapy for early-stage biliary tract cancerKumiko Umemoto, Yosuke Togashi, Yasuhito Arai, et al.
EJNMMI Research|June 2, 2026
GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Atsushi Doi, et al.
Science Immunology|October 7, 2022
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumorsKota Itahashi, Takuma Irie, Junichiro Yuda, et al.
Cancer Science|September 24, 2025
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With NivolumabTokiyoshi Tanegashima, Masaki Shiota, Shusuke Akamatsu, et al.
Cancer Immunology, Immunotherapy : CII|February 2, 2023
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trialMasaki Shiota, Hideaki Miyake, Masayuki Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC studyLeandro Blas, Masaki Shiota, Hideaki Miyake, et al.
Science Immunology|November 12, 2021
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escapeYoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, et al.
JCO Clinical Cancer Informatics|April 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC StudyMasaki Shiota, Shota Nemoto, Ryo Ikegami, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2024
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC StudyTokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, et al.
International Journal of Clinical Oncology|July 8, 2024
Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvementTokiyoshi Tanegashima, Masaki Shiota, Takahiro Kimura, et al.
Pageof 4